McLaren, Karmanos listed among best oncology programs in US

McLaren Health Care has been included on the 2023 list of “100 hospitals and health systems with great oncology programs” compiled by Becker’s Hospital Review. The health system has Michigan’s largest network of oncology centers, the Karmanos Cancer Network, anchored by the Barbara Ann Karmanos Cancer Institute in Detroit.

The list includes the premier providers of cancer care from across the country, many of which are National Cancer Institute (NCI)-Designated Oncology Centers. The oncology programs provide novel treatments, conduct cutting-edge research, hold clinical trials, and uphold safety designations to improve patient outcomes.

“The inclusion of McLaren and Karmanos on this list, placing our organization among the nation’s leaders, verifies and validates the dedication, commitment, and work of so many,” said Dr. Justin Klamerus, McLaren Health Care Executive Vice President and Chief Clinical Officer. “It’s a significant point of pride that we’re able to provide an exceptional level of cancer care throughout the state, and it’s also a responsibility and level of trust we fully appreciate.”

The Karmanos headquarters has been an NCI-Designated Comprehensive Cancer Center for 45 years, was the first in Michigan to receive this recognition, and holds the only NCI recognition in metro Detroit. As McLaren’s oncology service line, Karmanos is at the forefront of developing and translating scientific knowledge from promising laboratory discoveries into new treatments. Cancer patients at Karmanos and at the Network locations throughout Michigan and Ohio receive an unmatched comprehensive approach, including access to therapies exclusively at Karmanos, innovative care, cancer prevention programs, and multidisciplinary teams of cancer specialists.

From groundbreaking research to the most up-to-date therapies and individualized treatment, Karmanos is leading the fight against cancer. Over 800 cancer-specific scientific investigations and 300 active clinical trials are available at Karmanos, and aimed at providing better treatments for more than 200 known cancers.

A leading healthcare industry outlet, the Becker’s Hospital Review editorial team accepted nominations and examined rankings from reputable organizations while compiling the list. The list is meant to shine a light on oncology programs that are at the forefront of their field.

For more information about Karmanos, click here. View the 2023 list of 100 hospitals and health systems with great oncology programs here.